These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 23644670)
1. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Parker B; Al-Husain A; Pemberton P; Yates AP; Ho P; Gorodkin R; Teh LS; Alexander MY; Bruce IN Ann Rheum Dis; 2014 Jun; 73(6):1144-50. PubMed ID: 23644670 [TBL] [Abstract][Full Text] [Related]
3. Circulating endothelial microparticles as a marker of cerebrovascular disease. Jung KH; Chu K; Lee ST; Park HK; Bahn JJ; Kim DH; Kim JH; Kim M; Kun Lee S; Roh JK Ann Neurol; 2009 Aug; 66(2):191-9. PubMed ID: 19743467 [TBL] [Abstract][Full Text] [Related]
4. Correlation between brachial artery flow-mediated dilation and endothelial microparticle levels for identifying endothelial dysfunction in children with Kawasaki disease. Ding YY; Ren Y; Feng X; Xu QQ; Sun L; Zhang JM; Dou JJ; Lv HT; Yan WH Pediatr Res; 2014 Mar; 75(3):453-8. PubMed ID: 24336465 [TBL] [Abstract][Full Text] [Related]
5. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Wright SA; O'Prey FM; McHenry MT; Leahey WJ; Devine AB; Duffy EM; Johnston DG; Finch MB; Bell AL; McVeigh GE Ann Rheum Dis; 2008 Jun; 67(6):841-8. PubMed ID: 17875549 [TBL] [Abstract][Full Text] [Related]
6. Improved endothelial function and decreased levels of endothelium-derived microparticles after transcatheter aortic valve implantation. Horn P; Stern D; Veulemans V; Heiss C; Zeus T; Merx MW; Kelm M; Westenfeld R EuroIntervention; 2015 Apr; 10(12):1456-63. PubMed ID: 25287265 [TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression. Mak A; Liu Y; Ho RC J Rheumatol; 2011 Jul; 38(7):1296-303. PubMed ID: 21459950 [TBL] [Abstract][Full Text] [Related]
8. Circulating CD62E+ microparticles and cardiovascular outcomes. Lee ST; Chu K; Jung KH; Kim JM; Moon HJ; Bahn JJ; Im WS; Sunwoo J; Moon J; Kim M; Lee SK; Roh JK PLoS One; 2012; 7(4):e35713. PubMed ID: 22563392 [TBL] [Abstract][Full Text] [Related]
9. Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy. da Silva EF; Fonseca FA; França CN; Ferreira PR; Izar MC; Salomão R; Camargo LM; Tenore SB; Lewi DS AIDS; 2011 Aug; 25(13):1595-601. PubMed ID: 21673561 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive Assessment of Endothelial Dysfunction in Egyptian Patients with Lupus Nephritis. Fayed A; Soliman A; El-Khasab SO; Hammad H; Magdy M; Abu-Sheaishaa MA; El Wahab HA; Hegazy MT Saudi J Kidney Dis Transpl; 2021; 32(3):671-679. PubMed ID: 35102908 [TBL] [Abstract][Full Text] [Related]
11. Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans. Wang JM; Yang Z; Xu MG; Chen L; Wang Y; Su C; Tao J Eur J Pharmacol; 2009 Jul; 614(1-3):77-83. PubMed ID: 19401197 [TBL] [Abstract][Full Text] [Related]
12. Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction. Li B; Huang Q; Lin C; Lu R; Wang T; Chen X; Liu Z; Liu Y; Wu J; Wu Y; Liao S; Ding X Life Sci; 2021 Jan; 265():118749. PubMed ID: 33220290 [TBL] [Abstract][Full Text] [Related]
13. Visit-to-visit and 24-h blood pressure variability: association with endothelial and smooth muscle function in African Americans. Diaz KM; Veerabhadrappa P; Kashem MA; Thakkar SR; Feairheller DL; Sturgeon KM; Ling C; Williamson ST; Kretzschmar J; Lee H; Grimm H; Babbitt DM; Vin C; Fan X; Crabbe DL; Brown MD J Hum Hypertens; 2013 Nov; 27(11):671-7. PubMed ID: 23615389 [TBL] [Abstract][Full Text] [Related]
14. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus. Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029 [TBL] [Abstract][Full Text] [Related]
15. Annexin A5 as independent predictive biomarker for subclinical atherosclerosis and endothelial dysfunction in systemic lupus erythematosus patients. Valer P; Paul B; Eugenia B; Camelia B Clin Lab; 2013; 59(3-4):359-67. PubMed ID: 23724626 [TBL] [Abstract][Full Text] [Related]